Roglans N - Search Results

1

Uncoupling protein-3 mRNA levels are increased in white adipose tissue and skeletal muscle of bezafibrate-treated rats.

Cabrero A, Llaverías G, Roglans N, Alegret M, Sánchez R, Adzet T, Laguna JC, Vázquez M. Cabrero A, et al. Among authors: roglans n. Biochem Biophys Res Commun. 1999 Jul 5;260(2):547-56. doi: 10.1006/bbrc.1999.0926. Biochem Biophys Res Commun. 1999. PMID: 10403804

2

Differential induction of stearoyl-CoA desaturase and acyl-CoA oxidase genes by fibrates in HepG2 cells.

Rodríguez C, Cabrero A, Roglans N, Adzet T, Sánchez RM, Vázquez M, Ciudad CJ, Laguna JC. Rodríguez C, et al. Among authors: roglans n. Biochem Pharmacol. 2001 Feb 1;61(3):357-64. doi: 10.1016/s0006-2952(00)00557-8. Biochem Pharmacol. 2001. PMID: 11172741

3

Bezafibrate induces acyl-CoA oxidase mRNA levels and fatty acid peroxisomal beta-oxidation in rat white adipose tissue.

Vázquez M, Roglans N, Cabrero A, Rodríguez C, Adzet T, Alegret M, Sánchez RM, Laguna JC. Vázquez M, et al. Among authors: roglans n. Mol Cell Biochem. 2001 Jan;216(1-2):71-8. doi: 10.1023/a:1011060615234. Mol Cell Biochem. 2001. PMID: 11216866

4

Increase in hepatic expression of SREBP-2 by gemfibrozil administration to rats.

Roglans N, Peris C, Verd JC, Alegret M, Vázquez M, Sánchez RM, Laguna JC. Roglans N, et al. Biochem Pharmacol. 2001 Sep 15;62(6):803-9. doi: 10.1016/s0006-2952(01)00701-8. Biochem Pharmacol. 2001. PMID: 11551527

5

High doses of atorvastatin and simvastatin induce key enzymes involved in VLDL production.

Roglans N, Verd JC, Peris C, Alegret M, Vázquez M, Adzet T, Díaz C, Hernández G, Laguna JC, Sánchez RM. Roglans N, et al. Lipids. 2002 May;37(5):445-54. doi: 10.1007/s11745-002-0916-0. Lipids. 2002. PMID: 12056585

6

Atorvastatin treatment induced peroxisome proliferator-activated receptor alpha expression and decreased plasma nonesterified fatty acids and liver triglyceride in fructose-fed rats.

Roglans N, Sanguino E, Peris C, Alegret M, Vázquez M, Adzet T, Díaz C, Hernández G, Laguna JC, Sánchez RM. Roglans N, et al. J Pharmacol Exp Ther. 2002 Jul;302(1):232-9. doi: 10.1124/jpet.302.1.232. J Pharmacol Exp Ther. 2002. PMID: 12065722

7

Fibrate treatment does not modify the expression of acyl coenzyme A oxidase in human liver.

Roglans N, Bellido A, Rodríguez C, Cabrero A, Novell F, Ros E, Zambón D, Laguna JC. Roglans N, et al. Clin Pharmacol Ther. 2002 Dec;72(6):692-701. doi: 10.1067/mcp.2002.128605. Clin Pharmacol Ther. 2002. PMID: 12496750 Clinical Trial.

8

Gemfibrozil increases the specific binding of rat-cortex nuclear extracts to a PPRE probe.

Sanguino E, Ramón M, Roglans N, Alegret M, Sánchez RM, Vázquez-Carrera M, Laguna JC. Sanguino E, et al. Among authors: roglans n. Life Sci. 2003 Oct 24;73(23):2927-37. doi: 10.1016/j.lfs.2003.04.001. Life Sci. 2003. PMID: 14519442

9

Fibrates modify the expression of key factors involved in bile-acid synthesis and biliary-lipid secretion in gallstone patients.

Roglans N, Vázquez-Carrera M, Alegret M, Novell F, Zambón D, Ros E, Laguna JC, Sánchez RM. Roglans N, et al. Eur J Clin Pharmacol. 2004 Feb;59(12):855-61. doi: 10.1007/s00228-003-0704-1. Epub 2003 Dec 18. Eur J Clin Pharmacol. 2004. PMID: 14685799 Clinical Trial.

10

Prevention of age-related changes in rat cortex transcription factor activator protein-1 by hypolipidemic drugs.

Sanguino E, Roglans N, Alegret M, Sánchez RM, Vázquez-Carrera M, Laguna JC. Sanguino E, et al. Among authors: roglans n. Biochem Pharmacol. 2004 Oct 1;68(7):1411-21. doi: 10.1016/j.bcp.2004.06.008. Biochem Pharmacol. 2004. PMID: 15345331

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

56 results

Search Page

Filters